NTLA
Intellia Therapeutics Inc
12.30$
+1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.7% | +1.9% | +3.5% | +0.3% | -1.6% | -2.7% | -1.0% | +99.5% | -92.4% | +484.1% | +94.6% | – | |
| – | -0.9% | -2.5% | +19.6% | -3.0% | 0.0% | -44.9% | +0.9% | -11.0% | +363.1% | -85.2% | +134.1% | – | |
| – | – | -1,055.9% | – | -66.4% | -79.5% | -2,981.6% | – | – | -88.8% | -7,623.3% | – | – | |
| – | -64.9% | +64.9% | -59.6% | +26.4% | -23.3% | -25.1% | -67.5% | -87.9% | +334.5% | -37.3% | +2,289.9% | – | |
| – | -42.2% | -87.2% | -509.9% | -68.1% | – | -37.8% | +13.3% | -100.7% | – | +140.8% | -213.5% | – | |
| – | +457.4% | -43.7% | -31.2% | +99.3% | -97.2% | -100.0% | – | +683.9% | -98.3% | +1,598.0% | +584.2% | – | |
| – | – | -192.3% | – | – | – | -179.5% | – | +69.6% | -201.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.